Effects of denosumab treatment in chronic liver disease patients with osteoporosis

BACKGROUND: Effective treatment of osteoporosis is essential for improving morbidity and health-related quality of life in chronic liver disease (CLD) patients. Denosumab has been shown to increase bone mineral density (BMD) and decrease the risk of osteoporotic fracture in the general population. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, Chisato, Saito, Mitsuru, Oikawa, Tsunekazu, Nakano, Masanori, Torisu, Yuichi, Saruta, Masayuki, Tsubota, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476181/
https://www.ncbi.nlm.nih.gov/pubmed/32952342
http://dx.doi.org/10.3748/wjg.v26.i33.4960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476181/
https://www.ncbi.nlm.nih.gov/pubmed/32952342
http://dx.doi.org/10.3748/wjg.v26.i33.4960

Ejemplares similares